Who Controls Suominen? The Nomination Board Behind a 49% Owner Bloc

Everyone following Suominen got the same dry press release last fall, the kind that usually goes straight to the recycle bin: the composition of the company's Shareholders' Nomination Board. Four names, three appointing shareholders, one line about duties. Corporate-governance boilerplate.

It is not boilerplate. In a company controlled by a tight group of owners, the Nomination Board is where control actually gets its power. Its job is to propose the size, membership, and pay of the board of directors to the annual meeting — which means the four people on it decide who is even offered up as a candidate to run a roughly EUR 400-million-turnover nonwovens business. Follow the appointments and you have drawn a map of who is really steering the company.

As of September 2025, that map is almost entirely owned. Ahlstrom Capital B.V. appointed Jyrki Vainionpää, Etola Group Oy appointed Mikael Etola, and Oy Etra Invest Ab appointed Ville Vuori, with the board's own chairman, Charles Héaulmé, filling the fourth seat. Three of the four seats belong to the company's three largest registered shareholders. And those names are not strangers to one another: Ahlstrom Capital sits inside the same Ahlström-family orbit as A. Ahlström, while Etola Group and Etra Invest are two vehicles of the same Etola family acting jointly. Before the most recent capital raise, that bloc together held 49.02% of Suominen's shares.

Now the part that should focus a retail investor's attention. Finland has a rule that normally protects minority shareholders: cross 30% of voting rights and you must make a mandatory tender offer to buy out the rest of the stock — the takeover safety valve. In June 2026 the Finnish Financial Supervisory Authority granted Ahlstrom Capital, A. Ahlström, and the Etola parties permanent exemptions from that obligation, so they could keep subscribing in Suominen's rights issue without being forced to bid for everyone else's shares. Not a one-off waiver for a single transaction — a permanent carve-out, handed to owners who already sat at roughly half the votes.

Why does a company controlled to that degree need to raise money? Read the balance sheet. Suominen is in what its own management calls an "unsatisfactory" stretch. Full-year 2025 net sales fell 10.8% to EUR 412.4 million, and the company posted a net loss of EUR 12.1 million, a deeper loss than 2024's EUR 5.3 million. Debt climbed — gearing rose to 80.7% from 51.7% — and management proposed no dividend for 2025 given the loss.

That is the backdrop for the June 2026 rights issue: gross proceeds of roughly EUR 28 million at EUR 0.36 a share, framed as a way to strengthen the balance sheet and secure financial flexibility. It was oversubscribed — about 106% of the shares on offer were taken, with the large majority of the 77.1 million new shares going to existing holders exercising their pre-emptive rights. The point for an outside shareholder: this repair was designed and underwritten by the same owners who control the board, and it dilutes anyone who could not or would not participate. In a controlled company, a dilutive capital raise is simultaneously a promise to fix the ship and a reminder of who steers it.

The succession news completes the picture. For the 2026 annual meeting, the Nomination Board proposed shrinking the board from seven to six members and elevating Ville Vuori — a nominee of owner-aligned Etra Invest — to chairman. Charles Héaulmé stepped down from the chair to become the company's president and CEO, and Andreas Ahlström, from the owning family's investment arm, was proposed for re-election. In other words, the people proposing the board and the people sitting on it are the same people, and they are handling the management change in-house.

Strip away the governance brochure and the load-bearing facts are three. Control is concentrated at nearly half the votes across two family blocs. The minority-protection trigger that normally fires at 30% has been permanently waived for those owners. And that bloc is funding, through dilution, a balance-sheet repair on the heels of a loss-making year.

This is not the kind of story my factor work treats gently, because the measured numbers are moving the wrong way: sales down double digits, the loss widening, leverage up, the payout gone. The group's argument is that the raise resets the balance sheet and that profitability improves in 2026. That is a real, testable claim — but a minority holder is hearing it from the party that runs the board and was excused from the usual duty to buy them out at the 30% line. The backstop retail investors normally lean on in a controlled stock has been waived, not tightened.

That reshapes the risk-reward in one specific way. If the business turns, the 49% bloc captures the upside like anyone else — except they also hold the board, the succession, and the underwriting. If it does not turn, minority shareholders have fewer exit rights than a typical Finnish listed company gives them, because the mandatory-bid safety net is gone. So the thing worth watching is not momentum; it is whether comparable EBITDA actually improves in 2026 and whether the recovery the owners are funding starts showing up in reported numbers. Until it does, the honest label for this stock is neither growth nor income. It is a controlled balance-sheet turnaround in which control is the feature — and the minority shareholder is, permanently, the passenger.